During the past 10 years, Genertec Universal Medical Group Co's highest 3-Year average EPS without NRI Growth Rate was 23.80% per year. The lowest was -6.20% per year. And the median was 14.20% per year.
Genertec Universal Medical Group Co EPS (Diluted) Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Genertec Universal Medical Group Co EPS (Diluted) Chart
Competitive Comparison of Genertec Universal Medical Group Co's EPS (Diluted)
For the Credit Services subindustry, Genertec Universal Medical Group Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genertec Universal Medical Group Co's PE Ratio Distribution in the Credit Services Industry
For the Credit Services industry and Financial Services sector, Genertec Universal Medical Group Co's PE Ratio distribution charts can be found below:
* The bar in red indicates where Genertec Universal Medical Group Co's PE Ratio falls into.
Genertec Universal Medical Group Co EPS (Diluted) Calculation
EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.
EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$1.08
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genertec Universal Medical Group Co (HKSE:02666) EPS (Diluted) Explanation
EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Genertec Universal Medical Group Co EPS (Diluted) Related Terms
Thank you for viewing the detailed overview of Genertec Universal Medical Group Co's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.
Genertec Universal Medical Group Co (HKSE:02666) Business Description
Genertec Universal Medical Group Co Ltd is principally engaged in providing financing to its customers under finance lease arrangements, the provision of advisory services, the sale of medical equipment as well as leases under operating lease arrangements, and the provision of other services. The Group has two business segments; The finance business comprises direct finance leasing, sale-and-leaseback, factoring, operating leases, and advisory services, and The hospital group business comprises medical services, hospital, and healthcare management, import and export trade, and domestic trade of medical-related goods and life cycle management of equipment assets. Geographically, it derives a majority of its revenue from Mainland China.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:02666 has been successfully added to your 